ScoreWhy is Beihai Gofar Chuanshan Biological Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.02%
- The company has been able to generate a Return on Capital Employed (avg) of 1.02% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 4.86% and Operating profit at -254.98% over the last 5 years
3
Flat results in Sep 25
- INTEREST(HY) At CNY 1.2 MM has Grown at 11.91%
- NET SALES(9M) At CNY 238.41 MM has Grown at -8.96%
- DEBT-EQUITY RATIO (HY) Highest at -9.54 %
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 24.36%, its profits have risen by 13.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beihai Gofar Chuanshan Biological Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beihai Gofar Chuanshan Biological Co., Ltd.
9.71%
1.48
34.88%
China Shanghai Composite
21.43%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.93%
EBIT Growth (5y)
-237.88%
EBIT to Interest (avg)
-15.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.42
Tax Ratio
0.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.02%
ROE (avg)
1.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.10
EV to EBIT
-79.38
EV to EBITDA
-124.21
EV to Capital Employed
4.60
EV to Sales
8.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.80%
ROE (Latest)
-5.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET PROFIT(HY)
Higher at CNY -29.6 MM
RAW MATERIAL COST(Y)
Fallen by -41.18% (YoY
-8What is not working for the Company
NET PROFIT(Q)
At CNY -7.54 MM has Fallen at -337.23%
OPERATING CASH FLOW(Y)
Lowest at CNY -10.77 MM
ROCE(HY)
Lowest at -13.48%
DEBT-EQUITY RATIO
(HY)
Highest at -9.21 %
Here's what is working for Beihai Gofar Chuanshan Biological Co., Ltd.
Raw Material Cost
Fallen by -41.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Beihai Gofar Chuanshan Biological Co., Ltd.
Net Profit
At CNY -7.54 MM has Fallen at -337.23%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY -10.77 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -9.21 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
